NTRK Gene Fusions: Novel Targets for Tumor-Agnostic Cancer Therapy
Pharma & biotech2018-06-20
4 Views
Advanced sequencing techniques have revolutionized the understanding of how cancer has developed and enabled treatment selection based on genomic characterization of the tumor.
Source: OncLive
The news, reports, views and opinions of authors (or source) expressed are their own and do not necessarily represent the views of CRWE World.
XPeng (NYSE: XPEV) Unveils Beta Version Navigation Guided Pilot Function
